Open access peer-reviewed chapter

The Effects of Asymmetric Dimethylarginine (ADMA), Nitric Oxide (NO) and Homocysteine (Hcy) on Progression of Mild Chronic Kidney Disease (CKD): Relationship Between Clinical and Biochemical Parameters

By A. Atamer, S. Alisir Ecder, Y. Atamer, Y. Kocyigit, N. Bozkurt Yigit and T. Ecder

Submitted: February 3rd 2011Reviewed: August 3rd 2011Published: March 16th 2012

DOI: 10.5772/26011

Downloaded: 1820

© 2012 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

A. Atamer, S. Alisir Ecder, Y. Atamer, Y. Kocyigit, N. Bozkurt Yigit and T. Ecder (March 16th 2012). The Effects of Asymmetric Dimethylarginine (ADMA), Nitric Oxide (NO) and Homocysteine (Hcy) on Progression of Mild Chronic Kidney Disease (CKD): Relationship Between Clinical and Biochemical Parameters, Chronic Kidney Disease Monika Göoz, IntechOpen, DOI: 10.5772/26011. Available from:

Embed this chapter on your site Copy to clipboard

<iframe src="http://www.intechopen.com/embed/chronic-kidney-disease/the-effects-of-asymmetric-dimethylarginine-adma-nitric-oxide-no-and-homocysteine-hcy-on-progression-" />

Embed this code snippet in the HTML of your website to show this chapter

chapter statistics

1820total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Neutrophil Activation and Erythrocyte Membrane Protein Composition in Stage 5 Chronic Kidney Disease Patients

By Elísio Costa, Luís Belo and Alice Santos-Silva

Related Book

First chapter

Kinetic Modeling and Adequacy of Dialysis

By Malgorzata Debowska, Bengt Lindholm and Jacek Waniewski

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

+3,550 Open Access Books

+57,400 Citations in Web of Science

+108,500 IntechOpen Authors and Academic Editors

+560,000 Unique visitors per month

More about us